PINNACLE ASSOCIATES LTD has opened a new $3.9M position in $PRCT, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 12-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $PRCT.
$PRCT Hedge Fund Activity
We have seen 143 institutional investors add shares of $PRCT stock to their portfolio, and 138 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALLIANCEBERNSTEIN L.P. added 1,262,928 shares (+58.6%) to their portfolio in Q3 2025, for an estimated $45,073,900
- AXA S.A. removed 850,490 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $30,353,988
- ARROWMARK COLORADO HOLDINGS LLC added 786,094 shares (+229.7%) to their portfolio in Q3 2025, for an estimated $28,055,694
- MACKENZIE FINANCIAL CORP added 745,778 shares (+105.2%) to their portfolio in Q3 2025, for an estimated $26,616,816
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 524,766 shares (+34.3%) to their portfolio in Q3 2025, for an estimated $18,728,898
- PRICE T ROWE ASSOCIATES INC /MD/ removed 447,258 shares (-33.8%) from their portfolio in Q3 2025, for an estimated $15,962,638
- ARTISAN PARTNERS LIMITED PARTNERSHIP added 378,844 shares (+38.4%) to their portfolio in Q3 2025, for an estimated $13,520,942
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PRCT Insider Trading Activity
$PRCT insiders have traded $PRCT stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $PRCT stock by insiders over the last 6 months:
- FREDERIC H MOLL purchased 20,000 shares for an estimated $785,138
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PRCT Analyst Ratings
Wall Street analysts have issued reports on $PRCT in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 12/18/2025
- UBS issued a "Buy" rating on 12/12/2025
- TD Cowen issued a "Buy" rating on 11/05/2025
- Oppenheimer issued a "Outperform" rating on 09/02/2025
To track analyst ratings and price targets for $PRCT, check out Quiver Quantitative's $PRCT forecast page.
$PRCT Price Targets
Multiple analysts have issued price targets for $PRCT recently. We have seen 8 analysts offer price targets for $PRCT in the last 6 months, with a median target of $50.5.
Here are some recent targets:
- Richard Newitter from Truist Securities set a target price of $47.0 on 12/18/2025
- Danielle Antalffy from UBS set a target price of $62.0 on 12/12/2025
- Craig Bijou from B of A Securities set a target price of $38.0 on 12/08/2025
- Patrick Wood from Morgan Stanley set a target price of $51.0 on 12/02/2025
- Joshua Jennings from TD Cowen set a target price of $50.0 on 11/05/2025
- Matt O'Brien from Piper Sandler set a target price of $50.0 on 11/05/2025
- Nathan Treybeck from Wells Fargo set a target price of $51.0 on 11/05/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $PRCT ticker page for more data.
